the use of dexmedetomidine as an analgesic after uvulopalatopharyngoplasty for obstructive sleep apnea.

Phase 4

Completed

• Conditions: obstructive sleep apnea; Respiratory - Sleep apnoea; Anaesthesiology - Anaesthetics

• Registration Number: ACTRN12609000731291
• Lead Sponsor: Dr.walid Abd El Mageed

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2009-08-25
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 39

Inclusion Criteria

frequent loud snoring and arousal from sleep.
-apnea-hypopnea index 20-40.

Exclusion Criteria

-history of ischemic heart disease.
-long term use of certain medications(beta blockers, sedative and analgesics).

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
postoperative visual analogue pain score[Pain scores were recorded using a VAS scale every 30 min during the first 2 h, every 60 min during the next 10 h and every 4 h during the next 36 hours postoperatively];postoperative morphine consumption by patient-controlled analgesia[at 12,24,36,48h postoperative.]

Secondary Outcome Measures

Name	Time	Method
postoperative morphine side effects.Most common morphine side effects are nausea and vomiting.The presence of nausea and vomiting was noted(by clinical observation of the patients) using a four-point scale (0=no nausea or vomiting, 1=mild nausea, 2=sever nausea, 3=retching or vomiting).[24h postoperative.];postoperative satisfaction score[24h postoperative.]